---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-007269"
form_type: "8-K"
ticker: "PGEN"
cik: "0001356090"
company_name: "PRECIGEN, INC."
filed_at: "2023-01-27T23:59:59+00:00"
generated_at: "2026-06-20T07:05:37.577311+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Precigen (PGEN) prices public offering of 42.9M shares at $1.75, net ~$71.2M

## Summary
- Underwriting agreement with J.P. Morgan Securities as lead for 42,857,143 firm shares at $1.75/share.
- Underwriters have 30-day option to purchase up to 6,428,571 additional shares.
- Net proceeds of approximately $71.2 million after underwriting discount and expenses.
- Offering made under existing shelf registration; use of proceeds for general corporate purposes.

## SEC filing metadata
- accession: 0001104659-23-007269
- form_type: 8-K
- ticker: PGEN
- cik: 0001356090
- company_name: PRECIGEN, INC.
- filed_at: 2023-01-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356090/000110465923007269/0001104659-23-007269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356090/000110465923007269/tm234545d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-007269
- JSON: https://secwatch.observer/filing/0001104659-23-007269.json
- Plain text: https://secwatch.observer/filing/0001104659-23-007269.txt

## Key facts
- Material Agreements
  PRECIGEN, INC. entered into Underwriting Agreement with J.P. Morgan Securities LLC, as representative of the several underwriters named therein valued at approximately $71.2 million (effective 2023-01-24).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: J.P. Morgan Securities LLC, as representative of the several underwriters named therein
  - Value: approximately $71.2 million
  - Effective: 2023-01-24
  source text: On January 24, 2023, Precigen, Inc. (“Precigen”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, as representative of the several underwriters named therein (the “Underwriters”), in connection with the underwritten public offering (the "Offering") of 42,857,143 shares (the “Firm Shares”) of Precigen common stock, no par value (“Common Stock”), at a price to the public of $1.75 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1356090/000110465923007269/0001104659-23-007269-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
